HIGHLIGHTS
- who: Zeyu Wang et al. from the Saint Louis University, United States have published the article: Response to pioglitazone in non-alcoholic fatty liver disease patients with vs. without type 2 diabetes: A meta-analysis of randomized controlled trials, in the Journal: (JOURNAL)
- what: This meta-analysis was carried out to compare the efficacy and safety of pioglitazone in treating NAFLD with vs. without T2DM. The article has not compared the effects of non-diabetes NAFLD with diabetes NAFLD, but only compared pioglitazone with different drugs.
- how: Few studies have compared pioglitazone with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.